Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

35 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effect of anti-OprF-OprI immunoglobulin on APACHE II score in a porcine two-hit model of hemorrhagic shock/resuscitation and pseudomonas aeruginosa sepsis.
Haberstroh J, Gilleland HE Jr, von Specht BU. Haberstroh J, et al. Among authors: gilleland he jr. Eur Surg Res. 2005 Sep-Oct;37(5):265-73. doi: 10.1159/000089232. Eur Surg Res. 2005. PMID: 16374008
Enhancement of the protective efficacy of an oprF DNA vaccine against Pseudomonas aeruginosa.
Price BM, Barten Legutki J, Galloway DR, von Specht BU, Gilleland LB, Gilleland HE Jr, Staczek J. Price BM, et al. Among authors: gilleland he jr. FEMS Immunol Med Microbiol. 2002 Jun 3;33(2):89-99. doi: 10.1111/j.1574-695X.2002.tb00577.x. FEMS Immunol Med Microbiol. 2002. PMID: 12052563 Free article.
Protection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P. aeruginosa.
Price BM, Galloway DR, Baker NR, Gilleland LB, Staczek J, Gilleland HE Jr. Price BM, et al. Among authors: gilleland he jr. Infect Immun. 2001 May;69(5):3510-5. doi: 10.1128/IAI.69.5.3510-3515.2001. Infect Immun. 2001. PMID: 11292786 Free PMC article.
Immunization with a chimeric tobacco mosaic virus containing an epitope of outer membrane protein F of Pseudomonas aeruginosa provides protection against challenge with P. aeruginosa.
Staczek J, Bendahmane M, Gilleland LB, Beachy RN, Gilleland HE Jr. Staczek J, et al. Among authors: gilleland he jr. Vaccine. 2000 Apr 28;18(21):2266-74. doi: 10.1016/s0264-410x(99)00571-x. Vaccine. 2000. PMID: 10717347
Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.
Mansouri E, Gabelsberger J, Knapp B, Hundt E, Lenz U, Hungerer KD, Gilleland HE Jr, Staczek J, Domdey H, von Specht BU. Mansouri E, et al. Among authors: gilleland he jr. Infect Immun. 1999 Mar;67(3):1461-70. doi: 10.1128/IAI.67.3.1461-1470.1999. Infect Immun. 1999. PMID: 10024596 Free PMC article.
A chimeric influenza virus expressing an epitope of outer membrane protein F of Pseudomonas aeruginosa affords protection against challenge with P. aeruginosa in a murine model of chronic pulmonary infection.
Staczek J, Gilleland HE Jr, Gilleland LB, Harty RN, GarcĂ­a-Sastre A, Engelhardt OG, Palese P. Staczek J, et al. Among authors: gilleland he jr. Infect Immun. 1998 Aug;66(8):3990-4. doi: 10.1128/IAI.66.8.3990-3994.1998. Infect Immun. 1998. PMID: 9673294 Free PMC article.
Low-frequency electromagnetic fields alter the replication cycle of MS2 bacteriophage.
Staczek J, Marino AA, Gilleland LB, Pizarro A, Gilleland HE Jr. Staczek J, et al. Among authors: gilleland he jr. Curr Microbiol. 1998 May;36(5):298-301. doi: 10.1007/s002849900313. Curr Microbiol. 1998. PMID: 9541567
Chimeric influenza viruses incorporating epitopes of outer membrane protein F as a vaccine against pulmonary infection with Pseudomonas aeruginosa.
Gilleland HE Jr, Gilleland LB, Staczek J, Harty RN, Garcia-Sastre A, Engelhardt OG, Palese P. Gilleland HE Jr, et al. Behring Inst Mitt. 1997 Feb;(98):291-301. Behring Inst Mitt. 1997. PMID: 9382753
Ability of synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa to afford protection against P. aeruginosa infection in a murine acute pneumonia model.
Hughes EE, Gilleland HE Jr. Hughes EE, et al. Among authors: gilleland he jr. Vaccine. 1995 Dec;13(18):1750-3. doi: 10.1016/0264-410x(95)00166-x. Vaccine. 1995. PMID: 8701588
35 results
Jump to page
Feedback